Drug Trial Radar · NCT04837170
Safety and Efficacy Evaluation of S (+) - Ketamine in Adults
Last checked: Nov 19, 2026Latest source record: Apr 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
12,000
Planned (sponsor's estimate)
Start
May 1, 2021
Primary completion
Jun 1, 2022
Study completion Jun 30, 2022
Sponsor
- Lead sponsor
- Chinese PLA General HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Jiangsu Provincial People's Hospital; Beijing Hospital; The Affiliated Hospital of Qingdao University; Renmin Hospital of Wuhan University; First Affiliated Hospital Xi'an Jiaotong University; First Affiliated Hospital, Sun Yat-Sen University; Shengjing Hospital; Southern Medical University, China
- First posted
- Apr 8, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multicenter, randomized, open-label, active controlled pragmatic clinical trial that evaluates the safety and efficacy of S (+) -ketamine for postoperative acute pain in adults in perioperative settings.
Conditions
- Postoperative Pain
- Adults
- Anesthesia
Interventions
Conventional therapy + S (+)-KetamineDrug
Patients who undergo general anesthesia using S(+)-ketamine hydrochloride for anesthesia induction,maintenance or postoperative analgesia.
Conventional therapyDrug
Receiving conventional therapy without S (+)-Ketamine hydrochloride injection. There is no restrictions in drugs, doses and incompatibility, the researchers can choose appropriate medication regimens based on clinical practice, but other NMDA receptor antagonists are not be allowed to use, such as dextromethorphan and amantadine.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The area under the broken line of NRS scoreTime frame: Hour 0-48 after surgery
- Opioid consumptionTime frame: Hour 0-48 after surgery
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.